Q4 2022 13F Holders as of 12/31/2022
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
87.4M
-
Number of holders
-
37
-
Total 13F shares, excl. options
-
23.5M
-
Shares change
-
+388K
-
Total reported value, excl. options
-
$38.7M
-
Value change
-
-$1.21M
-
Number of buys
-
25
-
Number of sells
-
-11
-
Price
-
$1.65
Significant Holders of Oncology Institute, Inc. - Common Stock, par value $0.0001 per share (TOI) as of Q4 2022
44 filings reported holding TOI - Oncology Institute, Inc. - Common Stock, par value $0.0001 per share as of Q4 2022.
Oncology Institute, Inc. - Common Stock, par value $0.0001 per share (TOI) has 37 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 23.5M shares
of 87.4M outstanding shares and own 26.84% of the company stock.
Largest 10 shareholders include FMR LLC (12M shares), DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (3.36M shares), VANGUARD GROUP INC (1.93M shares), BlackRock Inc. (1.6M shares), Redmile Group, LLC (1.58M shares), GEODE CAPITAL MANAGEMENT, LLC (530K shares), Triatomic Management LP (517K shares), STATE STREET CORP (419K shares), Prosight Management, LP (276K shares), and NORTHERN TRUST CORP (257K shares).
This table shows the top 37 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.